Selection of Neospora caninum antigens stimulating bovine CD4+ve T cell responses through immuno-potency screening and proteomic approaches

Veterinary Research

Volumn 42, Issue 1, 2011, Pages

  Rocchi, Mara S ^a   Bartley, Paul M ^a   Inglis, Neil F ^a   Collantes Fernandez, Esther ^b   Entrican, Gary ^a   Katzer, Frank ^a   Innes, Elisabeth A ^a  

^a MOREDUN RESEARCH INSTITUTE   (United Kingdom)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BOS; BOVINAE; NEOSPORA CANINUM; TOXOPLASMA GONDII;

PARASITE ANTIGEN;

ANIMAL; ANIMAL DISEASE; ARTICLE; CATTLE; CATTLE DISEASE; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; COCCIDIOSIS; ELECTROSPRAY MASS SPECTROMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMUNOLOGY; MALE; METABOLISM; NEOSPORA; PARASITOLOGY; PROTEOMICS; TANDEM MASS SPECTROMETRY; TOXOPLASMA;

ANIMALS; ANTIGENS, PROTOZOAN; CATTLE; CATTLE DISEASES; CD4-POSITIVE T-LYMPHOCYTES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COCCIDIOSIS; IMMUNITY, CELLULAR; MALE; NEOSPORA; PROTEOMICS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; TANDEM MASS SPECTROMETRY; TOXOPLASMA;

EID: 84860555024     PISSN: 09284249     EISSN: 12979716     Source Type: Journal    
DOI: 10.1186/1297-9716-42-91     Document Type: Article

References (70)

1. Epidemiology and control of neosporosis and Neospora caninum. Dubey JP, Schares G, Ortega-Mora LM, Clin Microbiol Rev 2007 20 323 367 10.1128/CMR.00031-06 17428888 (Pubitemid 46709307)
2. Neosporosis. Aspects of epidemiology and host immune response. Innes EA, Buxton D, Maley S, Wright S, Marks J, Esteban I, Rae A, Schock A, Wastling J, Ann N Y Acad Sci 2000 916 93 101 11193706 (Pubitemid 32061080)
3. Risk factors associated with Neospora caninum seropositivity in randomly sampled Canadian dairy cows and herds. Vanleeuwen JA, Haddad JP, Dohoo IR, Keefe GP, Tiwari A, Scott HM, Prev Vet Med 2010 93 129 138 10.1016/j.prevetmed.2009. 11.013 20018395
4. Neospora caninum emerges from the shadow of Toxoplasma gondii. Innes EA, Mattsson JG, Trends Parasitol 2007 23 43 44 10.1016/j.pt.2006.12.004 17185039 (Pubitemid 46176742)
5. Herdsure Cattle Health Improvement Service. http://www.defra.gov.uk/vla/ vlascientific/vlas-herdsure.htm
6. Protecting babies: vaccine strategies to prevent foetopathy in Neospora caninum-infected cattle. Williams DJ, Trees AJ, Parasite Immunol 2006 28 61 67 10.1111/j.1365-3024.2005.00809.x 16441503
7. Immune responses to Neospora caninum and prospects for vaccination. Innes EA, Andrianarivo AG, Bjorkman C, Williams DJ, Conrad PA, Trends Parasitol 2002 18 497 504 10.1016/S1471-4922(02)02372-3 12473366 (Pubitemid 35441264)
8. Bovilis Neoguard. http://www.intervetusa.com/binaries/NeoGuard- TechInfoSheet-6184-tcm130-126552.pdf
9. Neospora caninum - how close are we to development of an efficacious vaccine that prevents abortion in cattle? Reichel MP, Ellis JT, Int J Parasitol 2009 39 1173 1187 10.1016/j.ijpara.2009.05.007 19497326
10. Effect of a killed whole Neospora caninum tachyzoite vaccine on the crude abortion rate of Costa Rican dairy cows under field conditions. Romero JJ, Perez E, Frankena K, Vet Parasitol 2004 123 149 159 10.1016/j.vetpar.2004.06.016 15325041 (Pubitemid 39485924)
11. Intervet symposium: Bovine neosporosis. Heuer C, Nicholson C, Russel D, Weston J, Vet Parasitol 2004 125 137 146
12. Current status of veterinary vaccines. Meeusen EN, Walker J, Peters A, Pastoret PP, Jungersen G, Clin Microbiol Rev 2007 20 489 510 10.1128/CMR.00005-07 17630337 (Pubitemid 47175016)
13. Inoculation of Balb/c mice with live attenuated tachyzoites protects against a lethal challenge of Neospora caninum. Bartley PM, Wright S, Chianini F, Buxton D, Innes EA, Parasitology 2008 135 13 21 17767798 (Pubitemid 350273743)
14. Immunisation of mice against neosporosis with recombinant NcSRS2 iscoms. Pinitkiatisakul S, Mattsson JG, Wikman M, Friedman M, Bengtsson KL, Stahl S, Lunden A, Vet Parasitol 2005 129 25 34 10.1016/j.vetpar.2004.12.004 15817199 (Pubitemid 40462558)
15. Predictive models and correlates of protection for testing biodefence vaccines. Williamson ED, Duchars MG, Kohberger R, Expert Rev Vaccines 2010 9 527 537 10.1586/erv.10.22 20450327
16. Immune responses in pregnant cattle and bovine fetuses following experimental infection with Neospora caninum. Andrianarivo AG, Barr BC, Anderson ML, Rowe JD, Packham AE, Sverlow KW, Conrad PA, Parasitol Res 2001 87 817 825 10.1007/s004360100442 11688887 (Pubitemid 32905580)
17. Neospora caninum-infected cattle develop parasite-specific CD4+ cytotoxic T lymphocytes. Staska LM, McGuire TC, Davies CJ, Lewin HA, Baszler TV, Infect Immun 2003 71 3272 3279 10.1128/IAI.71.6.3272-3279.2003 12761108 (Pubitemid 36637552)
18. Interferon gamma inhibits the intracellular multiplication of Neospora caninum, as shown by incorporation of 3H uracil. Innes EA, Panton WR, Marks J, Trees AJ, Holmdahl J, Buxton D, J Comp Pathol 1995 113 95 100 10.1016/S0021-9975(05)80075-1 7490344
19. Specific anti-Neospora caninum IgG1 and IgG2 antibody responses during gestation in naturally infected cattle and their relationship with gamma interferon production. Almeria S, Nogareda C, Santolaria P, Garcia-Ispierto I, Yaniz JL, Lopez-Gatius F, Vet Immunol Immunopathol 2009 130 35 42 10.1016/j.vetimm.2009.01.003 19201036
20. Maternal and fetal immune responses of cattle inoculated with Neospora caninum at mid-gestation. Bartley PM, Kirvar E, Wright S, Swales C, Esteban-Redondo I, Buxton D, Maley SW, Schock A, Rae AG, Hamilton C, Innes EA, J Comp Pathol 2004 130 81 91 10.1016/j.jcpa.2003.08.003 15003463 (Pubitemid 38279322)
21. Identification of vaccine candidate peptides in the NcSRS2 surface protein of Neospora caninum by using CD4+ cytotoxic T lymphocytes and gamma interferon-secreting T lymphocytes of infected holstein cattle. Staska LM, Davies CJ, Brown WC, McGuire TC, Suarez CE, Park JY, Mathison BA, Abbott JR, Baszler TV, Infect Immun 2005 73 1321 1329 10.1128/IAI.73.3.1321-1329.2005 15731029 (Pubitemid 40470717)
22. The protozoan Neospora caninum directly triggers bovine NK cells to produce gamma interferon and to kill infected fibroblasts. Boysen P, Klevar S, Olsen I, Storset AK, Infect Immun 2006 74 953 960 10.1128/IAI.74.2.953-960.2006 16428740 (Pubitemid 43185530)
23. Newly recognized fatal protozoan disease of dogs. Dubey JP, Carpenter JL, Speer CA, Topper MJ, Uggla A, J Am Vet Med Assoc 1988 192 1269 1285 3391851
24. Immunization of cattle with live tachyzoites of Neospora caninum confers protection against fetal death. Williams DJ, Guy CS, Smith RF, Ellis J, Björkman C, Reichel MP, Trees AJ, Infect Immun 2007 75 1343 1348 10.1128/IAI.00777-06 17145943 (Pubitemid 46385827)
25. The host-parasite relationship in pregnant cattle infected with Neospora caninum. Innes EA, Parasitology 2007 134 1903 1910 17958926 (Pubitemid 350014552)
26. Monensin use against Neospora caninum challenge in dairy cattle. VanLeeuwen JA, Greenwood S, Clark F, Acorn A, Markham F, McCarron J, O'Handley R, Vet Parasitol 2011 175 372 376 10.1016/j.vetpar.2010.10.016 21106293
27. Neosporosis and bovine abortion in Scotland. Buxton D, Caldow GL, Maley SW, Marks J, Innes EA, Vet Rec 1997 141 649 651 9466384 (Pubitemid 128497150)
28. Protection against vertical transmission in bovine neosporosis. Innes EA, Wright SE, Maley S, Rae A, Schock A, Kirvar E, Bartley P, Hamilton C, Carey IM, Buxton D, Int J Parasitol 2001 31 1523 1534 10.1016/S0020-7519(01)00284-3 11595240 (Pubitemid 32947007)
29. Long-term passage of tachyzoites in tissue culture can attenuate virulence of Neospora caninum in vivo. Bartley PM, Wright S, Sales J, Chianini F, Buxton D, Innes EA, Parasitology 2006 133 421 432 10.1017/S0031182006000539 16762097 (Pubitemid 44605834)
30. The kinetics of Theileria parva infection and lymphocyte transformation in vitro. Rocchi MS, Ballingall KT, MacHugh ND, McKeever DJ, Int J Parasitol 2006 36 771 778 10.1016/j.ijpara.2006.02.017 16696979 (Pubitemid 43890917)
31. Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Shevchenko A, Wilm M, Vorm O, Mann M, Anal Chem 1996 68 850 858 10.1021/ac950914h 8779443 (Pubitemid 26101214)
32. Ultra-fast tandem mass spectrometry scanning combined with monolithic column liquid chromatography increases throughput in proteomic analysis. Batycka M, Inglis NF, Cook K, Adam A, Fraser-Pitt D, Smith DG, Main L, Lubben A, Kessler BM, Rapid Commun Mass Spectrom 2006 20 2074 2080 10.1002/rcm.2563 16773668 (Pubitemid 44049032)
33. NCBInr database. http://www.ncbi.nlm.nih.gov/dbEST/index.html
34. Neospora caninum genomic database. http://www.sanger.ac.uk/cgi-bin/blast/ submitblast/n-caninum
35. Rules governing protein identification by mass spectrometry. Taylor GK, Goodlett DR, Rapid Commun Mass Spectrom 2005 19 3420 10.1002/rcm.2225 16252315 (Pubitemid 41691915)
36. The major 36 kDa Neospora caninum tachyzoite surface protein is closely related to the major Toxoplasma gondii surface antigen. Sonda S, Fuchs N, Connolly B, Fernandez P, Gottstein B, Hemphill A, Mol Biochem Parasitol 1998 97 97 108 10.1016/S0166-6851(98)00133-9 9879890 (Pubitemid 28558705)
37. Identification and partial characterization of a 36 kDa surface protein on Neospora caninum tachyzoites. Hemphill A, Fuchs N, Sonda S, Gottstein B, Hentrich B, Parasitology 1997 115 Pt 4 371 380 9364563 (Pubitemid 27448511)
38. The p29 and p35 immunodominant antigens of Neospora caninum tachyzoites are homologous to the family of surface antigens of Toxoplasma gondii. Howe DK, Crawford AC, Lindsay D, Sibley LD, Infect Immun 1998 66 5322 5328 9784539 (Pubitemid 29044626)
39. Protective efficacy of vaccination by recombinant vaccinia virus against Neospora caninum infection. Nishikawa Y, Inoue N, Xuan X, Nagasawa H, Igarashi I, Fujisaki K, Otsuka H, Mikami T, Vaccine 2001 19 1381 1390 10.1016/S0264-410X(00)00389-3 11163660 (Pubitemid 32332723)
40. Vaccination of mice against experimental Neospora caninum infection using NcSAG1- and NcSRS2-based recombinant antigens and DNA vaccines. Cannas A, Naguleswaran A, Muller N, Eperon S, Gottstein B, Hemphill A, Parasitology 2003 126 303 312 10.1017/S0031182002002895 12741509 (Pubitemid 36520944)
41. Protective efficacy of vaccination with Neospora caninum multiple recombinant antigens against experimental Neospora caninum infection. Cho JH, Chung WS, Song KJ, Na BK, Kang SW, Song CY, Kim TS, Korean J Parasitol 2005 43 19 25 10.3347/kjp.2005.43.1.19 15793355
42. Comparison of the major antigens of Neospora caninum and Toxoplasma gondii. Howe DK, Sibley LD, Int J Parasitol 1999 29 1489 1496 10.1016/S0020-7519(99)00099-5 10608434 (Pubitemid 29528158)
43. Subcellular localization and functional characterization of Nc-p43, a major Neospora caninum tachyzoite surface protein. Hemphill A, Infect Immun 1996 64 4279 4287 8926100 (Pubitemid 26318154)
44. Characterization of a cDNA-clone encoding Nc-p43, a major Neospora caninum tachyzoite surface protein. Hemphill A, Felleisen R, Connolly B, Gottstein B, Hentrich B, Muller N, Parasitology 1997 115 Pt 6 581 590 9488869 (Pubitemid 28078654)
45. Neospora caninum: antibodies directed against tachyzoite surface protein NcSRS2 inhibit parasite attachment and invasion of placental trophoblasts in vitro. Haldorson GJ, Stanton JB, Mathison BA, Suarez CE, Baszler TV, Exp Parasitol 2006 112 172 178 10.1016/j.exppara.2005.11.004 16375893 (Pubitemid 43247777)
46. Surface antigens of Toxoplasma gondii: variations on a theme. Lekutis C, Ferguson DJ, Grigg ME, Camps M, Boothroyd JC, Int J Parasitol 2001 31 1285 1292 10.1016/S0020-7519(01)00261-2 11566296 (Pubitemid 32868708)
47. The SRS superfamily of Toxoplasma surface proteins. Jung C, Lee CY, Grigg ME, Int J Parasitol 2004 34 285 296 10.1016/j.ijpara.2003.12.004 15003490 (Pubitemid 38299179)
48. Immunization with native surface protein NcSRS2 induces a Th2 immune response and reduces congenital Neospora caninum transmission in mice. Haldorson GJ, Mathison BA, Wenberg K, Conrad PA, Dubey JP, Trees AJ, Yamane I, Baszler TV, Int J Parasitol 2005 35 1407 1415 10.1016/j.ijpara.2005.05.013 16051244 (Pubitemid 41484154)
49. Delivery of Neospora caninum surface protein, NcSRS2 (Nc-p43), to mouse using recombinant vaccinia virus. Nishikawa Y, Kousaka Y, Fukumoto S, Xuan X, Nagasawa H, Igarashi I, Fujisaki K, Otsuka H, Mikami T, Parasitol Res 2000 86 934 939 10.1007/s004360000267 11097303
50. Bovine immune response to inoculation with Neospora caninum surface antigen SRS2 lipopeptides mimics immune response to infection with live parasites. Baszler TV, Shkap V, Mwangi W, Davies CJ, Mathison BA, Mazuz M, Resnikov D, Fish L, Leibovitch B, Staska LM, Savitsky I, Clin Vaccine Immunol 2008 15 659 667 10.1128/CVI.00436-07 18305105 (Pubitemid 351967056)
51. Isolation, characterization and expression of a GRA2 homologue from Neospora caninum. Ellis JT, Ryce C, Atkinson R, Balu S, Jones P, Harper PA, Parasitology 2000 120 Pt 4 383 390 10811279 (Pubitemid 30204308)
52. Dense-granule organelles of Toxoplasma gondii: their role in the host-parasite relationship. Cesbron-Delauw MF, Parasitol Today 1994 10 293 296 10.1016/0169-4758(94)90078-7 15275422
53. Toxoplasma gondii uses unusual sorting mechanisms to deliver transmembrane proteins into the host-cell vacuole. Gendrin C, Mercier C, Braun L, Musset K, Dubremetz JF, Cesbron-Delauw MF, Traffic 2008 9 1665 1680 10.1111/j.1600-0854.2008.00793.x 18631244
54. Identification of antigenic proteins from Neospora caninum recognized by bovine immunoglobulins M, E, A and G using immunoproteomics. Shin YS, Lee EG, Shin GW, Kim YR, Lee EY, Kim JH, Jang H, Gershwin LJ, Kim DY, Kim YH, Kim GS, Suh MD, Jung TS, Proteomics 2004 4 3600 3609 10.1002/pmic.200400963 15449377 (Pubitemid 39525310)
55. Evaluation of recombinant proteins of Neospora caninum as vaccine candidates (in a mouse model). Ellis J, Miller C, Quinn H, Ryce C, Reichel MP, Vaccine 2008 26 5989 5996 10.1016/j.vaccine.2008.08.043 18789996
56. Prevention of lethal experimental infection of C57BL/6 mice by vaccination with Brucella abortus strain RB51 expressing Neospora caninum antigens. Ramamoorthy S, Sanakkayala N, Vemulapalli R, Duncan RB, Lindsay DS, Schurig GS, Boyle SM, Kasimanickam R, Sriranganathan N, Int J Parasitol 2007 37 1521 1529 10.1016/j.ijpara.2007.04.020 17568587 (Pubitemid 47417972)
57. Apical organelles and host-cell invasion by Apicomplexa. Dubremetz JF, Garcia-Reguet N, Conseil V, Fourmaux MN, Int J Parasitol 1998 28 1007 1013 10.1016/S0020-7519(98)00076-9 9724870 (Pubitemid 28364727)
58. Identification of a Neospora caninum microneme protein (NcMIC1) which interacts with sulfated host cell surface glycosaminoglycans. Keller N, Naguleswaran A, Cannas A, Vonlaufen N, Bienz M, Bjorkman C, Bohne W, Hemphill A, Infect Immun 2002 70 3187 3198 10.1128/IAI.70.6.3187-3198.2002 12011014 (Pubitemid 34564183)
59. The novel coccidian micronemal protein MIC11 undergoes proteolytic maturation by sequential cleavage to remove an internal propeptide. Harper JM, Zhou XW, Pszenny V, Kafsack BF, Carruthers VB, Int J Parasitol 2004 34 1047 1058 10.1016/j.ijpara.2004.05.006 15313131 (Pubitemid 39093804)
60. Identification and characterization of a Neospora caninum microneme-associated protein (NcMIC4) that exhibits unique lactose-binding properties. Keller N, Riesen M, Naguleswaran A, Vonlaufen N, Stettler R, Leepin A, Wastling JM, Hemphill A, Infect Immun 2004 72 4791 4800 10.1128/IAI.72.8. 4791-4800.2004 15271941 (Pubitemid 38989339)
61. Vaccination with microneme protein NcMIC4 increases mortality in mice inoculated with Neospora caninum. Srinivasan S, Mueller J, Suana A, Hemphill A, J Parasitol 2007 93 1046 1055 10.1645/GE-1181R1.1 18163338 (Pubitemid 350211655)
62. Reduced infection and protection from clinical signs of cerebral neosporosis in C57BL/6 mice vaccinated with recombinant microneme antigen NcMIC1. Alaeddine F, Keller N, Leepin A, Hemphill A, J Parasitol 2005 91 657 665 10.1645/GE-401R 16108562 (Pubitemid 40993458)
63. Immunization of mice with plasmid DNA coding for NcGRA7 or NcsHSP33 confers partial protection against vertical transmission of Neospora caninum. Liddell S, Parker C, Vinyard B, Jenkins M, Dubey JP, J Parasitol 2003 89 496 500 10.1645/GE-2969 12880248 (Pubitemid 36828518)
64. Vaccination of mice with recombinant NcROP2 antigen reduces mortality and cerebral infection in mice infected with Neospora caninum tachyzoites. Debache K, Guionaud C, Alaeddine F, Mevissen M, Hemphill A, Int J Parasitol 2008 38 1455 1463 10.1016/j.ijpara.2008.04.001 18495126
65. Vaccination with recombinant NcROP2 combined with recombinant NcMIC1 and NcMIC3 reduces cerebral infection and vertical transmission in mice experimentally infected with Neospora caninum tachyzoites. Debache K, Alaeddine F, Guionaud C, Monney T, Müller J, Strohbusch M, Leib SL, Grandgirard D, Hemphill A, Int J Parasitol 2009 39 1373 1384 10.1016/j.ijpara.2009.04.006 19447110
66. Microarray analyses of mouse responses to infection by Neospora caninum identifies disease associated cellular pathways in the host response. Ellis J, Sinclair D, Morrison D, Al-Qassab S, Springett K, Ivens A, Mol Biochem Parasitol 2010 174 117 127 10.1016/j.molbiopara.2010.08.007 20817048
67. Characterization of anti-Neospora caninum hyperimmune rabbit serum by western blot analysis and immunoelectron microscopy. Barta JR, Dubey JP, Parasitol Res 1992 78 689 694 10.1007/BF00931522 1480607
68. Toxoplasma gondii rhoptry discharge correlates with activation of the early growth response 2 host cell transcription factor. Phelps ED, Sweeney KR, Blader IJ, Infect Immun 2008 76 4703 4712 10.1128/IAI.01447-07 18678671
69. Identification of Neospora antigens recognized by CD4+ T cells and immune sera from experimentally infected cattle. Marks J, Lunden A, Harkins D, Innes E, Parasite Immunol 1998 20 303 309 10.1046/j.1365-3024.1998.00145.x 9717191 (Pubitemid 28328003)
70. Neospora caninum antigens defined by antigen-dependent bovine CD4+ T cells. Tuo W, Fetterer RH, Davis WC, Jenkins MC, Dubey JP, J Parasitol 2005 91 564 568 10.1645/GE-386R 16108548 (Pubitemid 40993444)